Thermogelling Anaesthetic Compositions
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application PCT/EP2011/055009, filed Mar 31, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,828,437 | Thermogelling Anaesthetic Compositions In force · Medium confidence | Palette Life Sciences AB | In force | Medium confidence | ||
| US 9,254,263 | Thermogelling Anaesthetic Compositions In force · Medium confidence | Palette Life Sciences AB | In force | Medium confidence | ||
| US 8,834,927 | Thermogelling Anaesthetic Compositions In force · Medium confidence | Palette Life Sciences AB | In force | Medium confidence |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.